ARCHIVES

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.

December 7, 2001

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

July 10, 1992

In Brief: Cowan to Direct Eppley Cancer Center; Nealon Retires From NCI Liaison Office

June 11, 1999

NCI Searching for Scientists With “Fire in Belly” As Associate Director for Biological Carcinogenesis

June 19, 1987

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

QOL Of Young Survivors Equal To Other Children

February 25, 2005